Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Serina Therapeutics Inc. (SER : AMX)

Sector: Healthcare

Close
(03-27-2026)
$2.27
Change
-$0.34 (-13.03%)
Volume 727,043
Open $2.64
Day Range $2.24 - $2.65
52 Week Low $1.22
52 Week High $7.92
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $27,953,141
Shares Outstanding 12,314,159
Book Value per Share -$7.83
Earnings per Share $1.63
Period
Loading......
Loading......

Legend

Serina Therapeutics Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
March 27, 2026 2.27
-$0.34 (-13.03%)
March 26, 2026 2.61
-$0.42 (-13.86%)
March 25, 2026 3.03
$0.60 (24.69%)
March 24, 2026 2.43
-$0.72 (-22.86%)
March 23, 2026 3.15
$0.61 (24.02%)
March 20, 2026 2.54
$0.06 (2.42%)
March 19, 2026 2.48
$1.20 (93.75%)
March 18, 2026 1.28
-$0.06 (-4.48%)
March 17, 2026 1.34
-$0.12 (-8.22%)
March 16, 2026 1.46
-$0.09 (-5.81%)
March 13, 2026 1.55
-$0.01 (-0.64%)
March 12, 2026 1.56
$0.06 (4.00%)
March 11, 2026 1.50
-$0.12 (-7.41%)
March 10, 2026 1.62
$0.03 (1.89%)
March 09, 2026 1.59
$0.06 (3.92%)
March 06, 2026 1.53
-$0.04 (-2.55%)
March 05, 2026 1.57
-$0.10 (-5.99%)
March 04, 2026 1.67
$0.00 (0.00%)
March 03, 2026 1.67
-$0.10 (-5.65%)
March 02, 2026 1.77
-$0.03 (-1.67%)
February 27, 2026 1.80
-$0.01 (-0.55%)
February 26, 2026 1.81
$0.04 (2.26%)
February 25, 2026 1.77
$0.10 (5.99%)
February 24, 2026 1.67
$0.10 (6.37%)
February 23, 2026 1.57
-$0.05 (-3.09%)
February 20, 2026 1.62
-$0.11 (-6.36%)
February 19, 2026 1.73
$0.05 (2.98%)
February 18, 2026 1.68
$0.03 (1.82%)
February 17, 2026 1.65
-$0.18 (-9.84%)
February 16, 2026 1.83
$0.00 (0.00%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports